Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Dendreon Corporation published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-6 of 6
» View wsbt.com items only
    Aug 22, 2011 |Story| Reuters

  1. Seattle Genetics cancer drug price may top $100,000

    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
    Reuters
    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost. The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first...

    Tags: Government Health Care, Physical Conditions, Science, Food and Drug Administration, Lymphoma

    2. Jun 1, 2010 |Story| KCPQ-LTV

  2. Seattle-Based 'Breakthrough' Cancer Treatment Helping Patients Survive Prostate Cancer

    A new FDA approved treatment developed in Seattle is offering hope for men fighting prostate cancer. Many in the medical world are calling Dendreon's 'Provenge Vaccine-A' cancer treatment a true breakthrough.
    A new FDA approved treatment developed in Seattle is offering hope for men fighting prostate cancer. Many in the medical world are calling Dendreon's 'Provenge Vaccine-A' cancer treatment a true breakthrough. The FDA approved Provenge vaccine, a first of...

    Tags: Chills, Fever, Immune System, Prostate Cancer, Cancer

    3. Mar 23, 2010 |Story| South Florida Sun-Sentinel

  3. Prostate Cancer Drug Shows Promise

    For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.
    The Associated Press
    For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found. The benefit was modest -...

    Tags: Biotechnology, Prostate, Science and Technology, Prostate Cancer, Health Treatments

    4. Apr 29, 2010 |Story| Los Angeles Times

  4. FDA approves immune-boosting therapy for prostate cancer

    The Food and Drug Administration approved a new immune-boosting therapy for prostate cancer on Thursday, the first therapeutic vaccine for cancer ever approved by the agency. The approval opens the door to a whole new approach to cancer therapy, adding a unique weapon to the arsenal of oncologists.
    The Food and Drug Administration approved a new immune-boosting therapy for prostate cancer on Thursday, the first therapeutic vaccine for cancer ever approved by the agency. The approval opens the door to a whole new approach to cancer therapy, adding...

    Tags: Florida, Pharmaceuticals, Biotechnology, Social Issues, Prostate Cancer

    5. Sep 21, 2009 |Story| KCPQ-LTV

  5. Is Washington Doing Enough to Retain Big Businesses and Jobs?

    Moving out... More and more of Washington's businesses are packing up and heading out of state.
    Web Reporter
    Moving out... More and more of Washington's businesses are packing up and heading out of state. The reason? Some say the state isn't doing what it needs to keep hometown companies happy. In a non-descript building on the outskirts of Auburn is the...

    Tags: Economy, Business and Finance, Companies and Corporations, Business Enterprises, Washington (U.S. state), Georgia

    6. Apr 29, 2009 |Story| South Florida Sun-Sentinel

  6. Prostate cancer vaccine gives hope

    An experimental treatment added four months to the lives of men with advanced prostate cancer in a study that tested an entirely new approach to fighting the disease, doctors reported Tuesday.
    The Associated Press
    An experimental treatment added four months to the lives of men with advanced prostate cancer in a study that tested an entirely new approach to fighting the disease, doctors reported Tuesday. Dendreon Corp.'s Provenge vaccine trains the immune system to...

    Tags: Pharmaceuticals, Prostate, Prostate Cancer, Men's Health, Health and Safety at School

Original site for Dendreon Corporation topic gallery.